Tesla
TSLA
Apple
AAPL
Meta Platforms
META
4
Microsoft
MSFT
5
Petroleo Brasileiro SA Petrobras
PBR
US Stock MarketDetailed Quotes
EW Edwards Lifesciences
- 70.460
- -0.490-0.69%
Close Mar 21 16:00 ET
- 70.460
- 0.0000.00%
Post 20:01 ET
41.42BMarket Cap10.11P/E (TTM)
70.935High69.821Low7.14MVolume70.620Open70.950Pre Close502.63MTurnover1.23%Turnover Ratio10.11P/E (Static)587.90MShares96.12052wk High4.14P/B41.00BFloat Cap58.93052wk Low--Dividend TTM581.84MShs Float131.730Historical High--Div YieldTTM1.57%Amplitude1.000Historical Low70.353Avg Price1Lot Size
Edwards Lifesciences Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -39.46%542.3M | -193.34%-127.5M | -14.51%351.8M | 1,005.65%371.5M | -117.03%-53.5M | -26.47%895.8M | -51.70%136.6M | 32.78%411.5M | -89.89%33.6M | 7.09%314.1M |
| Net income from continuing operations | 197.96%4.17B | 3.95%384.3M | 699.95%3.07B | 19.48%365M | 3.08%351M | -8.05%1.4B | -7.20%369.7M | 11.70%383.7M | -24.83%305.5M | -8.86%340.5M |
| Operating gains losses | -5,300.00%-5.2M | --3.33B | ---- | ---- | ---- | -99.81%100K | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 7.11%155.2M | 16.08%42.6M | -6.50%34.5M | 9.70%39.6M | 9.38%38.5M | 3.80%144.9M | 3.67%36.7M | 4.24%36.9M | 5.87%36.1M | 1.44%35.2M |
| Deferred tax | -18.85%-323.4M | -7.77%-98.5M | -167.39%-123M | 20.27%-66.1M | 30.89%-35.8M | -6.92%-272.1M | 13.61%-91.4M | 0.65%-46M | -38.63%-82.9M | -21.60%-51.8M |
| Other non cash items | -32,378.85%-3.36B | -47,377.46%-3.36B | -205.45%-17.4M | 146.92%9.9M | -8.86%7.2M | 1,400.00%10.4M | -24.47%7.1M | 466.67%16.5M | 30.36%-21.1M | -67.89%7.9M |
| Change In working capital | 50.73%-259.3M | -114.30%-463.1M | 5,703.28%683.6M | 91.38%-20.8M | -710.95%-459M | -24.89%-526.3M | -154.53%-216.1M | 89.34%-12.2M | -160.69%-241.4M | 56.26%-56.6M |
| -Change in receivables | 185.84%121.2M | 681.87%105.9M | 3,538.46%47.3M | 149.15%23M | 29.03%-55M | -67.90%-141.2M | -1,554.55%-18.2M | 124.53%1.3M | -135.18%-46.8M | -34.08%-77.5M |
| -Change in inventory | 11.38%-256.1M | 48.44%-51.2M | 45.79%-41.2M | -16.44%-94.2M | -111.89%-69.5M | -35.43%-289M | -59.39%-99.3M | -16.39%-76M | -30.91%-80.9M | -36.67%-32.8M |
| -Change in prepaid assets | 116.17%31M | 83.85%-2.6M | 41.21%-10.7M | 112.87%17.2M | 213.87%27.1M | -191,800.00%-191.7M | 20.30%-16.1M | -237.04%-18.2M | -656.67%-133.6M | -1,500.00%-23.8M |
| -Change in payables and accrued expense | -53.36%52.7M | -159.09%-15.6M | -30.12%17.4M | 87.11%145.2M | -493.08%-94.3M | 270.18%113M | 3.94%26.4M | 159.38%24.9M | 335.96%77.6M | 86.66%-15.9M |
| -Change in other working capital | -1,095.98%-208.1M | -358.77%-499.6M | 1,102.15%670.8M | -94.11%-112M | -386.19%-267.3M | 69.79%-17.4M | -307.87%-108.9M | 216.01%55.8M | -9.49%-57.7M | 33.62%93.4M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -39.46%542.3M | -193.34%-127.5M | -14.51%351.8M | 1,005.65%371.5M | -117.03%-53.5M | -26.47%895.8M | -51.70%136.6M | 32.78%411.5M | -89.89%33.6M | 7.09%314.1M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 1,230.78%2.31B | -4,190.07%-576.7M | 2,935.62%2.7B | 77.78%124.8M | 12,520.00%63.1M | -31.11%173.8M | -85.11%14.1M | 144.17%89M | -45.83%70.2M | -99.78%500K |
| Capital expenditure reported | 0.24%-252.4M | 43.60%-49.8M | 6.15%-51.9M | -78.29%-85.4M | -6.18%-65.3M | -3.43%-253M | -28.16%-88.3M | 7.68%-55.3M | -11.14%-47.9M | 15.41%-61.5M |
| Net intangibles purchase and sale | -125.56%-30M | ---4.6M | ---5.4M | --0 | -52.67%-20M | 34.16%-13.3M | --0 | --0 | ---200K | ---13.1M |
| Net business purchase and sale | 3,110.08%2.87B | -748.26%-298.2M | --3.16B | --0 | --0 | ---95.2M | --46M | --0 | --0 | ---141.2M |
| Net investment purchase and sale | -122.02%-134.4M | -293.65%-152.6M | -315.87%-368.7M | 83.29%233.7M | -34.31%153.2M | 5.19%610.3M | -58.64%78.8M | 240.69%170.8M | -39.63%127.5M | -22.24%233.2M |
| Net other investing changes | -81.20%-135.9M | -219.20%-71.5M | -36.23%-36.1M | -155.43%-23.5M | 71.60%-4.8M | -18.86%-75M | -234.33%-22.4M | -31.19%-26.5M | 76.10%-9.2M | -834.78%-16.9M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 1,230.78%2.31B | -4,190.07%-576.7M | 2,935.62%2.7B | 77.78%124.8M | 12,520.00%63.1M | -31.11%173.8M | -85.11%14.1M | 144.17%89M | -45.83%70.2M | -99.78%500K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -38.26%-983M | 106.92%28.6M | -581.58%-976.7M | -285.41%-96.6M | 129.86%61.7M | 55.13%-711M | 50.72%-413.2M | -105.01%-143.3M | 116.91%52.1M | 43.87%-206.6M |
| Net common stock issuance | -31.81%-1.16B | 77.68%-100.1M | -416.63%-901M | -2,008.00%-158.1M | 99.92%-200K | 49.07%-879.6M | 48.22%-448.4M | -73.71%-174.4M | 97.89%-7.5M | 38.54%-249.3M |
| Proceeds from stock option exercised by employees | 5.65%179.5M | -13.86%28.6M | 1.47%34.5M | -10.69%54.3M | 48.21%62.1M | 16.05%169.9M | 20.73%33.2M | 4.94%34M | 24.08%60.8M | 11.73%41.9M |
| Net other financing activities | -138.46%-3.1M | 4,905.00%100.1M | -3,700.00%-110.2M | 700.00%7.2M | -125.00%-200K | 65.79%-1.3M | 1,900.00%2M | -52.63%-2.9M | ---1.2M | --800K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -38.26%-983M | 106.92%28.6M | -581.58%-976.7M | -285.41%-96.6M | 129.86%61.7M | 55.13%-711M | 50.72%-413.2M | -105.01%-143.3M | 116.91%52.1M | 43.87%-206.6M |
| Net cash flow | ||||||||||
| Beginning cash position | 48.59%1.15B | 160.51%3.68B | 58.29%1.66B | 40.23%1.23B | 48.59%1.15B | -10.93%772.6M | 12.96%1.41B | -12.92%1.05B | -15.35%876.4M | -10.93%772.6M |
| Current changes in cash | 422.09%1.87B | -157.37%-675.6M | 481.41%2.08B | 156.38%399.7M | -33.98%71.3M | 414.56%358.6M | 43.05%-262.5M | 827.79%357.2M | 1.43%155.9M | -30.19%108M |
| Effect of exchange rate changes | 129.76%38.6M | 1,600.00%51M | -659.78%-51.5M | 93.42%29.4M | 330.95%9.7M | -12.50%16.8M | 81.32%-3.4M | -10.68%9.2M | 9.35%15.2M | -131.82%-4.2M |
| End cash Position | 166.45%3.06B | 166.45%3.06B | 160.51%3.68B | 58.29%1.66B | 40.23%1.23B | 48.59%1.15B | 48.59%1.15B | 12.96%1.41B | -12.92%1.05B | -15.35%876.4M |
| Free cash flow | -58.71%259.9M | -476.60%-181.9M | -17.32%294.5M | 2,073.10%286.1M | -157.95%-138.8M | -33.97%629.5M | -75.06%48.3M | 42.48%356.2M | -105.02%-14.5M | 8.57%239.5M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings